J. Berger and D. E. Moller, The mechanisms of action of PPARs, Annu Rev Med, vol.53, pp.409-435, 2002.

F. Djouadi, J. P. Bonnefont, and L. Thuillier, Correction of fatty acid oxidation in carnitine palmitoyl transferase II-deficient cultured skin fibroblasts by bezafibrate, Pediatr Res, vol.54, pp.446-451, 2003.

F. Djouadi, F. Aubey, D. Schlemmer, and J. Bastin, Peroxisome proliferator activated receptor ? (PPAR?) agonist but not PPAR? corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells, J Clin Endocrinol Metab, vol.90, pp.1791-1797, 2005.

F. Djouadi, F. Aubey, and D. Schlemmer, Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders, Hum Mol Genet, vol.14, pp.2695-2703, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-02896287

N. Gregersen, P. Bross, and B. S. Andresen, Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships, Eur J Biochem, vol.271, pp.470-482, 2004.

P. Rinaldo, D. Matern, and M. J. Bennett, Fatty acid oxidation disorders, Annu Rev Physiol, vol.64, pp.477-502, 2002.